Ricky N Bluthenthal1, Lynn Wenger2, Daniel Chu3, Brendan Quinn4, James Thing3, Alex H Kral2. 1. Department of Preventive Medicine, Institute for Prevention Research, Keck School of Medicine, University of Southern California Soto Street Building, SSB 2001 N. Soto Street, MC 9239, Los Angeles, CA 90033, USA. Electronic address: rbluthen@usc.edu. 2. Urban Health Program, RTI International, 351 California St., San Francisco, CA 94104, USA. 3. Department of Preventive Medicine, Institute for Prevention Research, Keck School of Medicine, University of Southern California Soto Street Building, SSB 2001 N. Soto Street, MC 9239, Los Angeles, CA 90033, USA. 4. Centre for Population Health, Burnet Institute, 85 Commercial Rd., Melbourne, VIC 3004, Australia.
Abstract
AIMS: Most people who inject drugs (PWID) were first initiated into injection by a current PWID. Few studies have examined PWID who assist others into drug injection. Our goal is to describe the prevalence of and risk factors for initiating someone into injection in the last 12 months. METHODS: We recruited a cross-sectional sample of PWID (N=605) in California from 2011 to 2013. We examined bivariate and multivariate risk factors for initiating someone into injection with a focus on behaviors that might encourage injection initiation such as injecting in front of non-PWID, describing how to inject to non-PWID, and willingness to initiate someone into drug injection. RESULTS: Having initiated someone into injection was reported by 34% of PWID overall and 7% in the last 12 months. Forty-four PWID had assisted 431 people into injection in the past year. Factors independently associated with initiating someone into injection in the last 12 months were self-reported likelihood of initiating someone in the future (Adjusted Odds Ratio [AOR]=7.09; 95% Confidence Interval [CI]=3.40, 14.79), having injected another PWID in past month (AOR=4.05; 95% confidence interval [CI]=1.94, 8.47), having described how to inject to non-injectors (2.61; 95% CI=1.19, 5.71), and non-injection powder cocaine use in past month (AOR=4.97; 95% CI=2.08, 11.84) while controlling for study site. CONCLUSION: Active PWID are important in facilitating the process of drug injection uptake. Interventions to reduce initiation should include efforts to change behaviors and intentions among PWID that are associated with injection uptake among others.
AIMS: Most people who inject drugs (PWID) were first initiated into injection by a current PWID. Few studies have examined PWID who assist others into drug injection. Our goal is to describe the prevalence of and risk factors for initiating someone into injection in the last 12 months. METHODS: We recruited a cross-sectional sample of PWID (N=605) in California from 2011 to 2013. We examined bivariate and multivariate risk factors for initiating someone into injection with a focus on behaviors that might encourage injection initiation such as injecting in front of non-PWID, describing how to inject to non-PWID, and willingness to initiate someone into drug injection. RESULTS: Having initiated someone into injection was reported by 34% of PWID overall and 7% in the last 12 months. Forty-four PWID had assisted 431 people into injection in the past year. Factors independently associated with initiating someone into injection in the last 12 months were self-reported likelihood of initiating someone in the future (Adjusted Odds Ratio [AOR]=7.09; 95% Confidence Interval [CI]=3.40, 14.79), having injected another PWID in past month (AOR=4.05; 95% confidence interval [CI]=1.94, 8.47), having described how to inject to non-injectors (2.61; 95% CI=1.19, 5.71), and non-injection powder cocaine use in past month (AOR=4.97; 95% CI=2.08, 11.84) while controlling for study site. CONCLUSION: Active PWID are important in facilitating the process of drug injection uptake. Interventions to reduce initiation should include efforts to change behaviors and intentions among PWID that are associated with injection uptake among others.
Authors: Paul K Nelson; Bradley M Mathers; Benjamin Cowie; Holly Hagan; Don Des Jarlais; Danielle Horyniak; Louisa Degenhardt Journal: Lancet Date: 2011-07-27 Impact factor: 79.321
Authors: Scott E Hadland; Dan Werb; Thomas Kerr; Eric Fu; Hong Wang; Julio S Montaner; Evan Wood Journal: Prev Med Date: 2012-08-28 Impact factor: 4.018
Authors: Stephanie R Dyal; Alex H Kral; Karina Dominguez Gonzalez; Lynn D Wenger; Ricky N Bluthenthal Journal: Am J Drug Alcohol Abuse Date: 2015-05-13 Impact factor: 3.829
Authors: Stephanie Navarro; Alex H Kral; Carol S Strike; Kelsey Simpson; Lynn Wenger; Ricky N Bluthenthal Journal: Subst Use Misuse Date: 2019-05-03 Impact factor: 2.164
Authors: Andy Guise; Jason Melo; Maria Luisa Mittal; Claudia Rafful; Jazmine Cuevas-Mota; Peter Davidson; Richard S Garfein; Dan Werb Journal: Int J Drug Policy Date: 2018-03-07
Authors: Kelsey A Simpson; Alex H Kral; Jesse L Goldshear; Lynn Wenger; Carol S Strike; Ricky N Bluthenthal Journal: Drug Alcohol Depend Date: 2020-02-05 Impact factor: 4.492
Authors: Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Jennifer Lorvick; Brendan Quinn; James P Thing; Alex H Kral Journal: Drug Alcohol Depend Date: 2015-02-19 Impact factor: 4.492
Authors: Anneli Uusküla; David M Barnes; Mait Raag; Ave Talu; Susan Tross; Don C Des Jarlais Journal: Drug Alcohol Depend Date: 2018-05-08 Impact factor: 4.492